세계의 경피 패치 시장 - 시장 규모, 점유율, 산업 동향 분석 보고서 : 최종 사용자별, 유통 채널별, 점착제 유형별, 패치 유형별, 지역별 전망 및 예측(2023-2030년)
Global Transdermal Patches Market Size, Share & Industry Trends Analysis Report By End User, By Distribution Channel, By Adhesive Type, By Patch Type, By Regional Outlook and Forecast, 2023 - 2030
상품코드:1397778
리서치사:KBV Research
발행일:2023년 12월
페이지 정보:영문 632 Pages
라이선스 & 가격 (부가세 별도)
한글목차
경피 패치 시장 규모는 예측 기간 동안 CAGR 5.1%로 성장할 전망이며, 2030년에는 85억 달러에 달할 것으로 예측됩니다. 2022년 시장 규모는 33억 5,996만 6,800개에 달했으며 성장률은 4.6%(2019-2022년)이었습니다.
그러나 패치에는 다양한 크기가 있으며 패치의 표면적에 따라 적용 가능한 약물의 양이 제한됩니다. 복용량이 많을수록 더 큰 패치가 필요하며 편안하게 부착 할 수있는 크기에는 실제 한계가 있습니다. 피부가 약물을 흡수하는 속도에도 한계가 있습니다. 패치가 한 번에 많은 약물을 투여하면 피부 흡수 능력을 초과 할 수 있으며 피부 염증 및 약물을 효과적으로 투여 할 수 없다는 잠재적 문제가 발생할 수 있습니다. 이러한 측면이 시장 성장을 방해할 수 있습니다.
팬데믹 유행의 초기 단계에서 세계의 봉쇄, 이동 제한 및 운송의 혼란은 의약품 공급 체인의 과제로 이어졌습니다. 이것은 경피 패치의 생산과 유통에 영향을 미치며 제조 및 배송 지연을 유발하였습니다. 헬스케어 시스템과 전문가의 초점은 팬데믹이 초래하는 당면의 과제에 대처하는 것으로 크게 이동했습니다. 팬데믹은 다양한 치료 영역에서 진행 및 계획 중 임상시험을 중단시켰습니다. 이 중단은 새로운 경피 흡수형 테이프 제형의 개발 및 승인에 영향을 미쳤습니다.
최종 사용자 전망
최종 사용자별로 보면, 시장은 재택 케어와 병원 및 진료소로 이분됩니다. 2022년에는 재택 간호 분야가 시장에서 가장 큰 판매 점유율을 차지했습니다. 패치는 비침습적이고 편리한 약물전달 방법입니다. 환자는 건강 관리 전문가를 필요로 하지 않으며 집에서 쉽게 패치할 수 있어 의료 시설에 자주 다닐 필요성을 줄일 수 있습니다. 이 편의성은 지속적인 투여가 필요한 만성 질환을 관리하는 환자에게 특히 유용합니다. 따라서 이 부문은 향후 수년간 수요가 증가할 것으로 예상됩니다.
유통 채널 전망
유통 채널에 따라 시장은 병원 약국, 소매 약국 및 온라인 약국으로 구분됩니다. 2022년에는 소매 약국 부문이 시장에서 큰 수익 점유율을 획득했습니다. 많은 경피 흡수 패치, 특히 진통 및 금연과 같은 일반적인 증상에 사용되는 것은 시판 중입니다. 소매 약국은 OTC 경피 패치의 주요 유통 기지 역할을 하며, 소비자는 의사의 처방전 없이 구입할 수 있습니다. 이러한 요인은 이 부문 수요를 촉진하는 것으로 보입니다.
점착제 유형의 전망
점착제의 유형에 따라 시장은 아크릴계 점착제, 실리콘계 점착제, 하이드로겔계 점착제 등으로 나뉩니다. 아크릴계 점착제 부문은 2022년 시장에서 가장 큰 수익 점유율을 기록했습니다. 아크릴계 접착제는 강력하고 내구성 있는 접착 특성으로 알려져 있습니다. 약물 전달을 제어하기 위해 피부에 장시간 접착이 필요한 경피 흡수 패치에서는 아크릴계 접착제의 우수한 접착 능력이 전체 패치의 효과에 기여합니다. 이들에 사용되는 많은 아크릴계 점착제는 피부 친화적인 방식으로 배합됩니다.
패치 유형 전망
패치 유형에 따라 시장은 접착제 내 약물 패치, 매트릭스 패치, 저장소 막 패치, 마이크로 니들 패치, 이온 토폴리시 패치, 베이퍼 패치로 구분됩니다. 저장소 막 패치 부문은 2022년 시장에서 유망한 성장률을 확보했습니다. 저장 막의 설계는 약물을 보다 제어된 정확한 방출을 가능하게 합니다. 일반적으로 반투막에 의해 피부에서 분리되는 약물 저장소로 구성됩니다. 이 막은 약물의 방출 속도를 제어하고 보다 예측 가능하고 지속적인 방출 프로파일을 제공합니다.
용도별 전망
용도별로 볼 때 시장은 통증 관리, 금연, 호르몬 대체 요법, 심혈관 장애, 중추 신경 장애 등으로 나뉩니다. 통증 관리 부문은 2022년 시장에서 가장 큰 판매 점유율을 기록했습니다. 골관절염, 신경장애성 통증, 근골격계 장애 등의 만성 통증 상태는 세계적으로 만연하고 있습니다. 이 제품은 진통제의 지속적이고 통제 된 방출을 제공하고 장기 통증을 관리하는 환자에게 가치있는 솔루션을 제공합니다.
지역별 전망
지역별로 볼 때 시장은 북미, 유럽, 아시아태평양, LAMEA로 구분됩니다. 2022년에는 북미 부문이 시장에서 가장 높은 매출 점유율을 획득했습니다. 미국과 캐나다를 포함한 북미는 당뇨병, 심혈관 장애, 만성 통증 등 만성 질환의 유병률이 높다는 특징이 있습니다. 경피 흡수 패치는 이러한 질병의 장기 관리에 편리하고 효과적인 약물 전달 수단을 제공합니다. 만성질환의 부담이 증가하고 있는 것이, 이 지역 수요 증가에 기여하고 있습니다.
시장의 대기업은 시장에서 경쟁력을 유지하기 위해 다양한 혁신적인 제품과 경쟁하고 있습니다. 위 그림은 이 시장에서 주요 기업의 매출 비율을 보여줍니다. 시장의 선도 기업은 다양한 산업 수요에 부응하기 위해 다양한 전략을 채택하고 있습니다. 이 시장의 주요 개발 전략은 인수 및 파트너십 및 협업입니다.
목차
제1장 시장 범위 및 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장 요람
주요 하이라이트
제3장 시장 개요
서문
개요
시장구성 및 시나리오
시장에 영향을 미치는 주요 요인
시장 성장 촉진요인
시장 성장 억제요인
제4장 경쟁 분석-세계
시장 점유율 분석(2022년)
Porter's Five Forces 분석
제5장 세계의 경피 패치 시장 : 최종 사용자별
세계의 재택 치료 환경 시장 : 지역별
세계의 병원 및 클리닉 시장 : 지역별
제6장 세계의 경피 패치 시장 : 유통 채널별
세계의 병원 약국 시장 : 지역별
세계의 소매 약국 시장 : 지역별
세계의 온라인 약국 시장 : 지역별
제7장 세계의 경피 패치 시장 : 접착제 유형별
세계의 아크릴계 접착제 시장 : 지역별
세계의 실리콘 접착제 시장 : 지역별
세계의 하이드로겔 접착제 시장 : 지역별
세계의 기타 시장 : 지역별
제8장 세계의 경피 패치 시장 : 패치 유형별
세계의 접착제 내 약물 패치 시장 : 지역별
세계의 매트릭스 패치 시장 : 지역별
세계의 저장소 막 패치 시장 :지역별
세계의 마이크로 니들 패치 시장 :지역별
세계의 이온 도입 패치 시장 :지역별
세계의 베이퍼 패치 시장 :지역별
제9장 세계의 경피 패치 시장 : 용도별
세계의 통증 관리 시장 : 지역별
세계의 금연 시장 : 지역별
세계의 호르몬 보충 요법 시장 : 지역별
세계의 심혈관 질환 시장 : 지역별
세계의 중추 신경계 질환 시장 : 지역별
세계의 다른 시장 레지오 : 지역별
제10장 세계의 경피 패치 시장 : 지역별
북미
북미 시장 : 국가별
미국
캐나다
멕시코
기타 북미
유럽
유럽 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽
아시아태평양
아시아태평양 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카, 중동 및 아프리카
라틴아메리카, 중동 및 아프리카 시장 : 국가별
브라질
아르헨티나
아랍에미리트(UAE)
사우디아라비아
남아프리카
나이지리아
기타 라틴아메리카, 중동 및 아프리카
제11장 기업 프로파일
Johnson & Johnson
Viatris, Inc(Mylan NV)
Boehringer Ingelheim International GmbH
Endo International PLC
Bayer AG
Nitto Denko Corporation
Cipla Limited
Amneal Pharmaceuticals, Inc
Novartis AG
AbbVie, Inc
제12장 경피 패치 시장 승리의 필수 조건
AJY
영문 목차
영문목차
The Global Transdermal Patches Market size is expected to reach $8.5 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 33,59,966.8 thousand units, experiencing a growth of 4.6% (2019-2022).
Cardiovascular diseases, including hypertension and angina, remain the leading causes of morbidity and mortality worldwide. Therefore, the cardiovascular disorder segment captured $413.3 million revenue in the market in 2022. The increasing prevalence of these disorders has driven the demand for innovative and efficient treatment options, positioning transdermal patches as a viable solution. Cardiovascular patients often require long-term medication to manage their conditions. These offer a convenient and patient-friendly alternative to oral medications, potentially improving patient adherence. These factors will pose lucrative growth prospects for the segment. Some of the factors impacting the market are improved patient convenience with these, growing aging population in various countries, and limited drug loading capacity.
Transdermal patches are easy to apply and can be administered by patients themselves without the need for healthcare professionals. This simplicity makes them an attractive option for individuals who prefer self-administration. Unlike oral medications or injections, these do not require water for administration or using needles. This makes them particularly convenient for patients who may have difficulty swallowing pills or who are averse to injections. In addition, these are non-invasive, eliminating the pain associated with injections and the discomfort of repeated needle use. Additionally, these are easy to apply, making them a user-friendly option for seniors with mobility or dexterity challenges. For individuals who may find it challenging to manage multiple medications with different dosing schedules, these offer a convenient way to administer drugs without the need for frequent manual dosing. Older adults may experience difficulty swallowing pills, a condition known as dysphagia. Transdermal patches eliminate the need for swallowing, providing an alternative for those who struggle with oral medication. These factors will help expand the market.
However, various patch sizes are available, and the quantity of medication that can be applied to one is limited by the surface area of the patch. Larger doses may require larger patches, and there are practical limits to how big a patch can be applied comfortably. The skin has limitations regarding the rate at which it can absorb drugs. If a patch delivers too much drug at once, it may exceed the skin's absorption capacity, leading to potential issues such as skin irritation or the inability to deliver the drug effectively. These aspects can hamper the growth of the market.
The global lockdowns, restrictions on movement, and disruptions in transportation during the early stages of the pandemic led to challenges in the supply chain for pharmaceutical products. This affected the production and distribution of transdermal patches, potentially causing delays in manufacturing and delivery. The focus of healthcare systems and professionals shifted significantly toward addressing the immediate challenges posed by the pandemic. The pandemic disrupted ongoing and planned clinical trials across various therapeutic areas. This interruption affected the development and regulatory approval of new transdermal patch products.
End User Outlook
On the basis of end user, the market is bifurcated into homecare settings and hospitals & clinics. In 2022, the homecare settings segment witnessed the maximum revenue share in the market. These offer a non-invasive and convenient method of drug delivery. Patients can easily apply the patches at home without the need for healthcare professionals, reducing the necessity for frequent visits to healthcare facilities. This convenience is particularly beneficial for individuals managing chronic conditions that require continuous medication. Therefore, the segment will witness a rise in demand in the coming years.
Distribution Channel Outlook
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment garnered a significant revenue share in the market. Many transdermal patches, especially those used for common conditions like pain relief or smoking cessation, are available over the counter. Retail pharmacies serve as key distribution points for OTC transdermal patches, allowing consumers to purchase without needing a doctor's prescription. These factors will propel the demand in the segment.
Adhesive Type Outlook
On the basis of adhesive type, the market is divided into acrylic adhesives, silicone adhesives, hydrogel adhesives, and others. The acrylic adhesives segment recorded the maximum revenue share in the market in 2022. Acrylic adhesives are known for their strong and durable adhesion properties. In the context of transdermal patches, which require prolonged adhesion to the skin for controlled drug delivery, the excellent bonding capabilities of acrylic adhesives contribute to the overall effectiveness of the patches. Many acrylic adhesives used in these are formulated to be skin-friendly.
Patch Type Outlook
Based on patch type, the market is segmented into drug-in-adhesive, matrix patches, reservoir membrane patches, microneedle patches, iontophoresis patches, and vapour patches. The reservoir membrane patches segment procured a promising growth rate in the market in 2022. The reservoir membrane design allows for a more controlled and precise release of drugs. It typically consists of a drug reservoir separated from the skin by a semipermeable membrane. This membrane controls the rate at which the drug is released, resulting in a more predictable and sustained release profile.
Application Outlook
Based on application, the market is divided into pain management, smoking cessation, hormone replacement therapy, cardiovascular disorder, central nervous system disorder, and others. The pain management segment recorded the maximum revenue share in the market in 2022. Chronic pain conditions, such as osteoarthritis, neuropathic pain, and musculoskeletal disorders, are prevalent worldwide. These offer a sustained and controlled release of analgesic medications, providing a valuable solution for patients managing long-term pain.
Regional Outlook
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America segment acquired the highest revenue share in the market. North America, including the United States and Canada, is characterized by a high prevalence of chronic diseases such as diabetes, cardiovascular disorders, and chronic pain conditions. Transdermal patches provide a convenient and effective means of delivering medications for long-term management of these conditions. The rising burden of chronic diseases has contributed to the growing demand in the region.
The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Acquisitions, and Partnerships & Collaborations.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, Viatris, Inc. (Mylan N.V.), Boehringer Ingelheim International GmbH, Endo International PLC, Bayer AG, Nitto Denko Corporation, Cipla Limited, Amneal Pharmaceuticals, Inc., Novartis AG, and AbbVie, Inc.
Scope of the Study
Market Segments covered in the Report:
By End User (Volume, Thousand Units, USD Billion, 2019-2030)
Homecare Settings
Hospitals & Clinics
By Distribution Channel (Volume, Thousand Units, USD Billion, 2019-2030)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Adhesive Type (Volume, Thousand Units, USD Billion, 2019-2030)
Acrylic Adhesives
Silicone Adhesives
Hydrogel Adhesives
Others
By Patch Type (Volume, Thousand Units, USD Billion, 2019-2030)
Drug-In-Adhesive
Matrix Patches
Reservoir Membrane Patches
Microneedle Patches
Iontophoresis Patches
Vapour Patches
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
Pain Management
Smoking Cessation
Hormone Replacement Therapy
Cardiovascular Disorder
Central Nervous System Disorder
Others
By Geography (Volume, Thousand Units, USD Billion, 2019-2030)
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
Johnson & Johnson
Viatris, Inc. (Mylan N.V.)
Boehringer Ingelheim International GmbH
Endo International PLC
Bayer AG
Nitto Denko Corporation
Cipla Limited
Amneal Pharmaceuticals, Inc.
Novartis AG
AbbVie, Inc.
Unique Offerings from KBV Research
Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Transdermal Patches Market, by End User
1.4.2 Global Transdermal Patches Market, by Distribution Channel
1.4.3 Global Transdermal Patches Market, by Adhesive Type
1.4.4 Global Transdermal Patches Market, by Patch Type
1.4.5 Global Transdermal Patches Market, by Application
1.4.6 Global Transdermal Patches Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Porter's Five Forces Analysis
Chapter 5. Global Transdermal Patches Market by End User
5.1 Global Homecare Settings Market by Region
5.2 Global Hospitals & Clinics Market by Region
Chapter 6. Global Transdermal Patches Market by Distribution Channel
6.1 Global Hospital Pharmacies Market by Region
6.2 Global Retail Pharmacies Market by Region
6.3 Global Online Pharmacies Market by Region
Chapter 7. Global Transdermal Patches Market by Adhesive Type
7.1 Global Acrylic Adhesives Market by Region
7.2 Global Silicone Adhesives Market by Region
7.3 Global Hydrogel Adhesives Market by Region
7.4 Global Others Market by Region
Chapter 8. Global Transdermal Patches Market by Patch Type
8.1 Global Drug-In-Adhesive Market by Region
8.2 Global Matrix Patches Market by Region
8.3 Global Reservoir Membrane Patches Market by Region
8.4 Global Microneedle Patches Market by Region
8.5 Global Iontophoresis Patches Market by Region
8.6 Global Vapour Patches Market by Region
Chapter 9. Global Transdermal Patches Market by Application
9.1 Global Pain Management Market by Region
9.2 Global Smoking Cessation Market by Region
9.3 Global Hormone Replacement Therapy Market by Region
9.4 Global Cardiovascular Disorder Market by Region
9.5 Global Central Nervous System Disorder Market by Region
9.6 Global Others Market by Regio
Chapter 10. Global Transdermal Patches Market by Region
10.1 North America Transdermal Patches Market
10.1.1 North America Transdermal Patches Market by End User
10.1.1.1 North America Homecare Settings Market by Region
10.1.1.2 North America Hospitals & Clinics Market by Region
10.1.2 North America Transdermal Patches Market by Distribution Channel
10.1.2.1 North America Hospital Pharmacies Market by Country
10.1.2.2 North America Retail Pharmacies Market by Country
10.1.2.3 North America Online Pharmacies Market by Country
10.1.3 North America Transdermal Patches Market by Adhesive Type
10.1.3.1 North America Acrylic Adhesives Market by Country
10.1.3.2 North America Silicone Adhesives Market by Country
10.1.3.3 North America Hydrogel Adhesives Market by Country
10.1.3.4 North America Others Market by Country
10.1.4 North America Transdermal Patches Market by Patch Type
10.1.4.1 North America Drug-In-Adhesive Market by Country
10.1.4.2 North America Matrix Patches Market by Country
10.1.4.3 North America Reservoir Membrane Patches Market by Country
10.1.4.4 North America Microneedle Patches Market by Country
10.1.4.5 North America Iontophoresis Patches Market by Country
10.1.4.6 North America Vapour Patches Market by Country
10.1.5 North America Transdermal Patches Market by Application
10.1.5.1 North America Pain Management Market by Country
10.1.5.2 North America Smoking Cessation Market by Country
10.1.5.3 North America Hormone Replacement Therapy Market by Country
10.1.5.4 North America Cardiovascular Disorder Market by Country
10.1.5.5 North America Central Nervous System Disorder Market by Country
10.1.5.6 North America Others Market by Country
10.1.6 North America Transdermal Patches Market by Country
10.1.6.1 US Transdermal Patches Market
10.1.6.1.1 US Transdermal Patches Market by End User
10.1.6.1.2 US Transdermal Patches Market by Distribution Channel
10.1.6.1.3 US Transdermal Patches Market by Adhesive Type
10.1.6.1.4 US Transdermal Patches Market by Patch Type
10.1.6.1.5 US Transdermal Patches Market by Application
10.1.6.2 Canada Transdermal Patches Market
10.1.6.2.1 Canada Transdermal Patches Market by End User
10.1.6.2.2 Canada Transdermal Patches Market by Distribution Channel
10.1.6.2.3 Canada Transdermal Patches Market by Adhesive Type
10.1.6.2.4 Canada Transdermal Patches Market by Patch Type
10.1.6.2.5 Canada Transdermal Patches Market by Application
10.1.6.3 Mexico Transdermal Patches Market
10.1.6.3.1 Mexico Transdermal Patches Market by End User
10.1.6.3.2 Mexico Transdermal Patches Market by Distribution Channel
10.1.6.3.3 Mexico Transdermal Patches Market by Adhesive Type
10.1.6.3.4 Mexico Transdermal Patches Market by Patch Type
10.1.6.3.5 Mexico Transdermal Patches Market by Application
10.1.6.4 Rest of North America Transdermal Patches Market
10.1.6.4.1 Rest of North America Transdermal Patches Market by End User
10.1.6.4.2 Rest of North America Transdermal Patches Market by Distribution Channel
10.1.6.4.3 Rest of North America Transdermal Patches Market by Adhesive Type
10.1.6.4.4 Rest of North America Transdermal Patches Market by Patch Type
10.1.6.4.5 Rest of North America Transdermal Patches Market by Application
10.2 Europe Transdermal Patches Market
10.2.1 Europe Transdermal Patches Market by End User
10.2.1.1 Europe Homecare Settings Market by Country
10.2.1.2 Europe Hospitals & Clinics Market by Country
10.2.2 Europe Transdermal Patches Market by Distribution Channel
10.2.2.1 Europe Hospital Pharmacies Market by Country
10.2.2.2 Europe Retail Pharmacies Market by Country
10.2.2.3 Europe Online Pharmacies Market by Country
10.2.3 Europe Transdermal Patches Market by Adhesive Type
10.2.3.1 Europe Acrylic Adhesives Market by Country
10.2.3.2 Europe Silicone Adhesives Market by Country
10.2.3.3 Europe Hydrogel Adhesives Market by Country
10.2.3.4 Europe Others Market by Country
10.2.4 Europe Transdermal Patches Market by Patch Type
10.2.4.1 Europe Drug-In-Adhesive Market by Country
10.2.4.2 Europe Matrix Patches Market by Country
10.2.4.3 Europe Reservoir Membrane Patches Market by Country
10.2.4.4 Europe Microneedle Patches Market by Country
10.2.4.5 Europe Iontophoresis Patches Market by Country
10.2.4.6 Europe Vapour Patches Market by Country
10.2.5 Europe Transdermal Patches Market by Application
10.2.5.1 Europe Pain Management Market by Country
10.2.5.2 Europe Smoking Cessation Market by Country
10.2.5.3 Europe Hormone Replacement Therapy Market by Country
10.2.5.4 Europe Cardiovascular Disorder Market by Country
10.2.5.5 Europe Central Nervous System Disorder Market by Country
10.2.5.6 Europe Others Market by Country
10.2.6 Europe Transdermal Patches Market by Country
10.2.6.1 Germany Transdermal Patches Market
10.2.6.1.1 Germany Transdermal Patches Market by End User
10.2.6.1.2 Germany Transdermal Patches Market by Distribution Channel
10.2.6.1.3 Germany Transdermal Patches Market by Adhesive Type
10.2.6.1.4 Germany Transdermal Patches Market by Patch Type
10.2.6.1.5 Germany Transdermal Patches Market by Application
10.2.6.2 UK Transdermal Patches Market
10.2.6.2.1 UK Transdermal Patches Market by End User
10.2.6.2.2 UK Transdermal Patches Market by Distribution Channel
10.2.6.2.3 UK Transdermal Patches Market by Adhesive Type
10.2.6.2.4 UK Transdermal Patches Market by Patch Type
10.2.6.2.5 UK Transdermal Patches Market by Application
10.2.6.3 France Transdermal Patches Market
10.2.6.3.1 France Transdermal Patches Market by End User
10.2.6.3.2 France Transdermal Patches Market by Distribution Channel
10.2.6.3.3 France Transdermal Patches Market by Adhesive Type
10.2.6.3.4 France Transdermal Patches Market by Patch Type
10.2.6.3.5 France Transdermal Patches Market by Application
10.2.6.4 Russia Transdermal Patches Market
10.2.6.4.1 Russia Transdermal Patches Market by End User
10.2.6.4.2 Russia Transdermal Patches Market by Distribution Channel
10.2.6.4.3 Russia Transdermal Patches Market by Adhesive Type
10.2.6.4.4 Russia Transdermal Patches Market by Patch Type
10.2.6.4.5 Russia Transdermal Patches Market by Application
10.2.6.5 Spain Transdermal Patches Market
10.2.6.5.1 Spain Transdermal Patches Market by End User
10.2.6.5.2 Spain Transdermal Patches Market by Distribution Channel
10.2.6.5.3 Spain Transdermal Patches Market by Adhesive Type
10.2.6.5.4 Spain Transdermal Patches Market by Patch Type
10.2.6.5.5 Spain Transdermal Patches Market by Application
10.2.6.6 Italy Transdermal Patches Market
10.2.6.6.1 Italy Transdermal Patches Market by End User
10.2.6.6.2 Italy Transdermal Patches Market by Distribution Channel
10.2.6.6.3 Italy Transdermal Patches Market by Adhesive Type
10.2.6.6.4 Italy Transdermal Patches Market by Patch Type
10.2.6.6.5 Italy Transdermal Patches Market by Application
10.2.6.7 Rest of Europe Transdermal Patches Market
10.2.6.7.1 Rest of Europe Transdermal Patches Market by End User
10.2.6.7.2 Rest of Europe Transdermal Patches Market by Distribution Channel
10.2.6.7.3 Rest of Europe Transdermal Patches Market by Adhesive Type
10.2.6.7.4 Rest of Europe Transdermal Patches Market by Patch Type
10.2.6.7.5 Rest of Europe Transdermal Patches Market by Application
10.3 Asia Pacific Transdermal Patches Market
10.3.1 Asia Pacific Transdermal Patches Market by End User
10.3.1.1 Asia Pacific Homecare Settings Market by Country
10.3.1.2 Asia Pacific Hospitals & Clinics Market by Country
10.3.2 Asia Pacific Transdermal Patches Market by Distribution Channel
10.3.2.1 Asia Pacific Hospital Pharmacies Market by Country
10.3.2.2 Asia Pacific Retail Pharmacies Market by Country
10.3.2.3 Asia Pacific Online Pharmacies Market by Country
10.3.3 Asia Pacific Transdermal Patches Market by Adhesive Type
10.3.3.1 Asia Pacific Acrylic Adhesives Market by Country
10.3.3.2 Asia Pacific Silicone Adhesives Market by Country
10.3.3.3 Asia Pacific Hydrogel Adhesives Market by Country
10.3.3.4 Asia Pacific Others Market by Country
10.3.4 Asia Pacific Transdermal Patches Market by Patch Type
10.3.4.1 Asia Pacific Drug-In-Adhesive Market by Country
10.3.4.2 Asia Pacific Matrix Patches Market by Country
10.3.4.3 Asia Pacific Reservoir Membrane Patches Market by Country
10.3.4.4 Asia Pacific Microneedle Patches Market by Country
10.3.4.5 Asia Pacific Iontophoresis Patches Market by Country
10.3.4.6 Asia Pacific Vapour Patches Market by Country
10.3.5 Asia Pacific Transdermal Patches Market by Application
10.3.5.1 Asia Pacific Pain Management Market by Country
10.3.5.2 Asia Pacific Smoking Cessation Market by Country
10.3.5.3 Asia Pacific Hormone Replacement Therapy Market by Country
10.3.5.4 Asia Pacific Cardiovascular Disorder Market by Country
10.3.5.5 Asia Pacific Central Nervous System Disorder Market by Country
10.3.5.6 Asia Pacific Others Market by Country
10.3.6 Asia Pacific Transdermal Patches Market by Country
10.3.6.1 China Transdermal Patches Market
10.3.6.1.1 China Transdermal Patches Market by End User
10.3.6.1.2 China Transdermal Patches Market by Distribution Channel
10.3.6.1.3 China Transdermal Patches Market by Adhesive Type
10.3.6.1.4 China Transdermal Patches Market by Patch Type
10.3.6.1.5 China Transdermal Patches Market by Application
10.3.6.2 Japan Transdermal Patches Market
10.3.6.2.1 Japan Transdermal Patches Market by End User
10.3.6.2.2 Japan Transdermal Patches Market by Distribution Channel
10.3.6.2.3 Japan Transdermal Patches Market by Adhesive Type
10.3.6.2.4 Japan Transdermal Patches Market by Patch Type
10.3.6.2.5 Japan Transdermal Patches Market by Application
10.3.6.3 India Transdermal Patches Market
10.3.6.3.1 India Transdermal Patches Market by End User
10.3.6.3.2 India Transdermal Patches Market by Distribution Channel
10.3.6.3.3 India Transdermal Patches Market by Adhesive Type
10.3.6.3.4 India Transdermal Patches Market by Patch Type
10.3.6.3.5 India Transdermal Patches Market by Application
10.3.6.4 South Korea Transdermal Patches Market
10.3.6.4.1 South Korea Transdermal Patches Market by End User
10.3.6.4.2 South Korea Transdermal Patches Market by Distribution Channel
10.3.6.4.3 South Korea Transdermal Patches Market by Adhesive Type
10.3.6.4.4 South Korea Transdermal Patches Market by Patch Type
10.3.6.4.5 South Korea Transdermal Patches Market by Application
10.3.6.5 Singapore Transdermal Patches Market
10.3.6.5.1 Singapore Transdermal Patches Market by End User
10.3.6.5.2 Singapore Transdermal Patches Market by Distribution Channel
10.3.6.5.3 Singapore Transdermal Patches Market by Adhesive Type
10.3.6.5.4 Singapore Transdermal Patches Market by Patch Type
10.3.6.5.5 Singapore Transdermal Patches Market by Application
10.3.6.6 Malaysia Transdermal Patches Market
10.3.6.6.1 Malaysia Transdermal Patches Market by End User
10.3.6.6.2 Malaysia Transdermal Patches Market by Distribution Channel
10.3.6.6.3 Malaysia Transdermal Patches Market by Adhesive Type
10.3.6.6.4 Malaysia Transdermal Patches Market by Patch Type
10.3.6.6.5 Malaysia Transdermal Patches Market by Application
10.3.6.7 Rest of Asia Pacific Transdermal Patches Market
10.3.6.7.1 Rest of Asia Pacific Transdermal Patches Market by End User
10.3.6.7.2 Rest of Asia Pacific Transdermal Patches Market by Distribution Channel
10.3.6.7.3 Rest of Asia Pacific Transdermal Patches Market by Adhesive Type
10.3.6.7.4 Rest of Asia Pacific Transdermal Patches Market by Patch Type
10.3.6.7.5 Rest of Asia Pacific Transdermal Patches Market by Application
10.4 LAMEA Transdermal Patches Market
10.4.1 LAMEA Transdermal Patches Market by End User
10.4.1.1 LAMEA Homecare Settings Market by Country
10.4.1.2 LAMEA Hospitals & Clinics Market by Country
10.4.2 LAMEA Transdermal Patches Market by Distribution Channel
10.4.2.1 LAMEA Hospital Pharmacies Market by Country
10.4.2.2 LAMEA Retail Pharmacies Market by Country
10.4.2.3 LAMEA Online Pharmacies Market by Country
10.4.3 LAMEA Transdermal Patches Market by Adhesive Type
10.4.3.1 LAMEA Acrylic Adhesives Market by Country
10.4.3.2 LAMEA Silicone Adhesives Market by Country
10.4.3.3 LAMEA Hydrogel Adhesives Market by Country
10.4.3.4 LAMEA Others Market by Country
10.4.4 LAMEA Transdermal Patches Market by Patch Type
10.4.4.1 LAMEA Drug-In-Adhesive Market by Country
10.4.4.2 LAMEA Matrix Patches Market by Country
10.4.4.3 LAMEA Reservoir Membrane Patches Market by Country
10.4.4.4 LAMEA Microneedle Patches Market by Country
10.4.4.5 LAMEA Iontophoresis Patches Market by Country
10.4.4.6 LAMEA Vapour Patches Market by Country
10.4.5 LAMEA Transdermal Patches Market by Application
10.4.5.1 LAMEA Pain Management Market by Country
10.4.5.2 LAMEA Smoking Cessation Market by Country
10.4.5.3 LAMEA Hormone Replacement Therapy Market by Country
10.4.5.4 LAMEA Cardiovascular Disorder Market by Country
10.4.5.5 LAMEA Central Nervous System Disorder Market by Country
10.4.5.6 LAMEA Others Market by Country
10.4.6 LAMEA Transdermal Patches Market by Country
10.4.6.1 Brazil Transdermal Patches Market
10.4.6.1.1 Brazil Transdermal Patches Market by End User
10.4.6.1.2 Brazil Transdermal Patches Market by Distribution Channel
10.4.6.1.3 Brazil Transdermal Patches Market by Adhesive Type
10.4.6.1.4 Brazil Transdermal Patches Market by Patch Type
10.4.6.1.5 Brazil Transdermal Patches Market by Application
10.4.6.2 Argentina Transdermal Patches Market
10.4.6.2.1 Argentina Transdermal Patches Market by End User
10.4.6.2.2 Argentina Transdermal Patches Market by Distribution Channel
10.4.6.2.3 Argentina Transdermal Patches Market by Adhesive Type
10.4.6.2.4 Argentina Transdermal Patches Market by Patch Type
10.4.6.2.5 Argentina Transdermal Patches Market by Application
10.4.6.3 UAE Transdermal Patches Market
10.4.6.3.1 UAE Transdermal Patches Market by End User
10.4.6.3.2 UAE Transdermal Patches Market by Distribution Channel
10.4.6.3.3 UAE Transdermal Patches Market by Adhesive Type
10.4.6.3.4 UAE Transdermal Patches Market by Patch Type
10.4.6.3.5 UAE Transdermal Patches Market by Application
10.4.6.4 Saudi Arabia Transdermal Patches Market
10.4.6.4.1 Saudi Arabia Transdermal Patches Market by End User
10.4.6.4.2 Saudi Arabia Transdermal Patches Market by Distribution Channel
10.4.6.4.3 Saudi Arabia Transdermal Patches Market by Adhesive Type
10.4.6.4.4 Saudi Arabia Transdermal Patches Market by Patch Type
10.4.6.4.5 Saudi Arabia Transdermal Patches Market by Application
10.4.6.5 South Africa Transdermal Patches Market
10.4.6.5.1 South Africa Transdermal Patches Market by End User
10.4.6.5.2 South Africa Transdermal Patches Market by Distribution Channel
10.4.6.5.3 South Africa Transdermal Patches Market by Adhesive Type
10.4.6.5.4 South Africa Transdermal Patches Market by Patch Type
10.4.6.5.5 South Africa Transdermal Patches Market by Application
10.4.6.6 Nigeria Transdermal Patches Market
10.4.6.6.1 Nigeria Transdermal Patches Market by End User
10.4.6.6.2 Nigeria Transdermal Patches Market by Distribution Channel
10.4.6.6.3 Nigeria Transdermal Patches Market by Adhesive Type
10.4.6.6.4 Nigeria Transdermal Patches Market by Patch Type
10.4.6.6.5 Nigeria Transdermal Patches Market by Application
10.4.6.7 Rest of LAMEA Transdermal Patches Market
10.4.6.7.1 Rest of LAMEA Transdermal Patches Market by End User
10.4.6.7.2 Rest of LAMEA Transdermal Patches Market by Distribution Channel
10.4.6.7.3 Rest of LAMEA Transdermal Patches Market by Adhesive Type
10.4.6.7.4 Rest of LAMEA Transdermal Patches Market by Patch Type
10.4.6.7.5 est of LAMEA Transdermal Patches Market by Application
Chapter 11. Company Profiles
11.1 Johnson & Johnson
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Viatris, Inc. (Mylan N.V.)
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.6 SWOT Analysis
11.3 Boehringer Ingelheim International GmbH
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional & Segmental Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Endo International PLC
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bayer AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 SWOT Analysis
11.6 Nitto Denko Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Cipla Limited
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.6 SWOT Analysis
11.8 Amneal Pharmaceuticals, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.6 SWOT Analysis
11.9 Novartis AG
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. AbbVie, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
Chapter 12. Winning Imperatives of Transdermal Patches Market